bpc-157 human clinical trial tendon healing - 5MG/10MG Musculoskeletal and Tissue Healing with
Description
The standard AOD 9604 dosage is 250500 mcg once daily, administered subcutaneously on an empty stomach every morning, and cycled in 412-week blocks
No LD50 (lethal dose) has been established because researchers have not been able to achieve lethal toxicity in test animals
Users must comply with institutional safety regulations, ethical standards, and applicable laws
But the really interesting question is why BPC-157 seems capable of accelerating healing across so many completely different tissues and organs
doi:10.3389/fphar.2022.972468
Third-party testing verification adds credibility
